Everence Capital Management Inc. trimmed its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 26.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,454 shares of the conglomerate’s stock after selling 10,430 shares during the period. Everence Capital Management Inc.’s holdings in Danaher were worth $6,532,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of the stock. Fort Pitt Capital Group LLC increased its holdings in shares of Danaher by 3.2% during the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after purchasing an additional 7,421 shares in the last quarter. Good Life Advisors LLC purchased a new position in Danaher in the third quarter valued at $217,000. Oak Thistle LLC acquired a new position in shares of Danaher in the second quarter worth about $363,000. Harvest Portfolios Group Inc. boosted its stake in shares of Danaher by 1.2% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after acquiring an additional 2,465 shares in the last quarter. Finally, Stifel Financial Corp grew its holdings in Danaher by 1.3% in the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock valued at $235,583,000 after purchasing an additional 11,216 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on the stock. Stifel Nicolaus upped their price objective on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Guggenheim began coverage on shares of Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 price target for the company. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective on the stock in a report on Thursday, October 31st. Stephens reissued an “overweight” rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Finally, UBS Group lowered their price target on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $287.05.
Danaher Trading Up 1.4 %
DHR traded up $3.26 on Friday, hitting $233.07. The company had a trading volume of 608,634 shares, compared to its average volume of 1,633,422. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm has a market cap of $168.34 billion, a P/E ratio of 44.48, a PEG ratio of 4.33 and a beta of 0.83. The company’s fifty day moving average price is $236.58 and its 200 day moving average price is $254.47. Danaher Co. has a 1 year low of $222.53 and a 1 year high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same period in the prior year, the business posted $2.02 EPS. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. As a group, equities analysts expect that Danaher Co. will post 7.5 earnings per share for the current year.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. Danaher’s dividend payout ratio is presently 20.61%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- Stock Sentiment Analysis: How it Works
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- ESG Stocks, What Investors Should Know
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
- What is a support level?
- MicroStrategy Feels Bitcoin’s Weight: 2 Smart Dips to Watch
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.